IP Verse

Composition Containing Apomorphine And A Divalent Metal Cation - EP3174526

The patent EP3174526 was granted to Britannia Pharmaceuticals on Mar 22, 2023. The application was originally filed on Jul 31, 2015 under application number EP15766745A. The patent is currently recorded with a legal status of "Patent Maintained As Amended".

EP3174526

BRITANNIA PHARMACEUTICALS
Application Number
EP15766745A
Filing Date
Jul 31, 2015
Status
Patent Maintained As Amended
Feb 17, 2023
Publication Date
Mar 22, 2023
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

EVER NEURO PHARMAJun 10, 2020VOSSIUS & PARTNER PATENTANWALTE RECHTSANWALTE MBB -

Patent Citations (5) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
EXAMINATIONUS6514482
INTERNATIONAL-SEARCH-REPORTEP2545905
INTERNATIONAL-SEARCH-REPORTUS2011111011
OPPOSITIONEP2545905
OPPOSITIONUS2011111011

Non-Patent Literature (NPL) Citations (9) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference Text
EXAMINATION- UGWOKE M I ET AL, "Toxicological investigations of the effects carboxymethylcellulose on ciliary beat frequency of human nasal epithelial cells in primary suspension culture and in vivo on rabbit nasal mucosa", INTERNATIONAL JOURNAL OF PHARMACEUTICS, ELSEVIER, NL, vol. 205, no. 1-2, ISSN 0378-5173, (20000915), pages 43 - 51, (20000915), XP027380064
OPPOSITION- APO-go® Ampoules 10 mg/ml - Solution for Injection or Infusion, (20180900), XP055753089
OPPOSITION- KHALIULIN I et al., "Cardioprotective and Antioxidant Effects of Apomorphine", Free Radic Res, (20030700), vol. 37, no. 7, pages 721 - 30
OPPOSITION- MALINOVSKAJA K et al., "Ion-exchange and Iontophoresis-Controlled Delivery of Apomorphine", Eur J Pharm Biopharm, (20121201), vol. 83, no. 3, doi:10.1016/j.ejpb.2012.11.014, pages 477 - 84
OPPOSITION- UGWOKE MI et al., "Toxicological Investigations of the Effects Carboxymethylcellulose on Ciliary Beat Frequency of Human Nasal Epithelial Cells in Primary Suspension Culture and in Vivo on Rabbit Nasal Mucosa", Int J Pharm, (20000915), vol. 205, no. 1-2, pages 43 - 51, XP027380064
OPPOSITION- YOUDIM MBH et al., "Iron Chelating, Antioxidant and Cytoprotective Properties of Dopamine Receptor Agonist; Apomorphine", J Neural Transm Suppl, (20000000), vol. 58, pages 83 - 96, XP055753087
OPPOSITION- KANTAK KM et al., "Enhancement of Apomorphine and I-Amphetamine-Induced Behaviors by Magnesium", Pharmacol Biochem Behav, (19900500), vol. 36, no. 1, doi:10.1016/0091-3057(90)90120-7, pages 29 - 33, XP025564621
OPPOSITION- MALINOVSKAJA K et al., "Ion-exchange and Iontophoresis-Controlled Delivery of Apomorphine", Eur J Pharm Biopharm, (20121201), vol. 83, no. 3, doi:10.1016/j.ejpb.2012.11.014, pages 477 - 84, XP029001867
OPPOSITION- KHALIULIN I et al., "Cardioprotective and Antioxidant Effects of Apomorphine", Free Radic Res, (20030700), vol. 37, no. 7, pages 721 - 30, XP055753084

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents